Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 10;8(55):31603-31607.
doi: 10.1039/c8ra06826g. eCollection 2018 Sep 5.

Acid-promoted iron-catalysed dehydrogenative [4 + 2] cycloaddition for the synthesis of quinolines under air

Jinfei Yang  1 , Xiao Meng  1 , Kai Lu  1 , Zhihao Lu  1 , Minliang Huang  1 , Chengniu Wang  1 , Fei Sun  1
Affiliations

Acid-promoted iron-catalysed dehydrogenative [4 + 2] cycloaddition for the synthesis of quinolines under air

Jinfei Yang et al. RSC Adv. .

Abstract

An acid-promoted iron-catalysed dehydrogenative [4 + 2] cycloaddition reaction was developed for the synthesis of quinolines using air as a terminal oxidant. Acetic acid was the best cocatalyst for the cycloaddition of N-alkyl anilines with alkenes or alkynes under air. Various quinoline derivatives were obtained in satisfactory-to-excellent yields, and no other byproducts besides water were produced in the reaction. The zebrafish model has become an important vertebrate model for evaluating drug effects. We tested the activity of 3n in zebrafish. The test results showed that 1 μg mL-13n treatments resulted in morphological malformation, and 0.01-0.1 μg mL-13n treatments led to potent angiogenic defects in zebrafish embryos. The results of this study will be of great significance for promoting drug research in cardiovascular and cerebrovascular diseases.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Scheme 1
Scheme 1. Different strategies for [4 + 2] cycloaddition of N-alkyl anilines and alkenes or alkynes by transition-metal catalysis.
Scheme 2
Scheme 2. Proposed strategy.
Scheme 3
Scheme 3. Reaction conditions: substrate 1 (0.2 mmol), aryl olefin (0.4 mmol), Fe(OTf)3 (10 μmol), AcOH (0.3 mmol), toluene (1.0 mL), at 140 °C under air for 24 h, and isolated yields of the products.
Scheme 4
Scheme 4. Reaction conditions: substrate 1 (0.2 mmol), aryl alkyne (0.4 mmol), Fe(OTf)3 (10 μmol), AcOH (0.3 mmol), toluene (1.0 mL), at 140 °C under air for 24 h, and isolated yields of the products.
Scheme 5
Scheme 5. Gram-scale synthesis and the drug effect of 3n treatment on vascular in the trunk of Tg(kdrl:EGFP) zebrafish embryos at 48 hpf. (A–D) control group and 1, 0.1, 0.01 μg mL−13n treated groups. Scale bar, 75 μm.
Scheme 6
Scheme 6. Mechanistic experiments.
See this image and copyright information in PMC

References

    1. For selected reviews, see:

    2. Danel A. Gondek E. Kityk I. Opt. Mater. 2009;32:267. doi: 10.1016/j.optmat.2009.09.008. - DOI
    3. Xu H. Chen R. Sun Q. Lai W. Su Q. Huang W. Liu X. Chem. Soc. Rev. 2014;43:3259. doi: 10.1039/C3CS60449G. - DOI - PubMed

    1. For selected reviews, see:

    2. Orhan Puskullu M. Tekiner B. Suzen S. Mini-Rev. Med. Chem. 2013;13:365. - PubMed
    3. Gopaul K. Shintre S. A. Koorbanally N. A. Anti-Cancer Agents Med. Chem. 2015;15:631. doi: 10.2174/1871520615666141216125446. - DOI - PubMed
    4. Afzal O. Kumar S. Haider M. R. Ali M. R. Kumar R. Jaggi M. Bawa S. Eur. J. Med. Chem. 2015;97:871. doi: 10.1016/j.ejmech.2014.07.044. - DOI - PubMed

    1. For selected reviews, see:

    2. ElSohly M. A. Gul W. Recent Pat. Anti-Infect. Drug Discovery. 2007;2:222. doi: 10.2174/157489107782497263. - DOI - PubMed
    3. Zhang Y. Han T. Ming Q. Wu L. Rahman K. Qin L. Nat. Prod. Commun. 2012;7:963. - PubMed
    4. Chung P.-Y. Bian Z.-X. Pun H.-Y. Chan D. Chan A. S.-C. Chui C.-H. Tang J. C.-O. Lam K.-H. Future Med. Chem. 2015;7:947. doi: 10.4155/fmc.15.34. - DOI - PubMed

    1. For related reviews, see:

    2. Marco-Contelles J. Pérez-Mayoral E. Samadi A. Carreiras M. d. C. Soriano E. Chem. Rev. 2009;109:2652. doi: 10.1021/cr800482c. - DOI - PubMed
    3. Majumder A. Gupta R. Jain A. Green Chem. Lett. Rev. 2013;6:151. doi: 10.1080/17518253.2012.733032. - DOI
    4. Prajapati S. M. Patel K. D. Vekariya R. H. Panchal S. N. Patel H. D. RSC Adv. 2014;4:24463. doi: 10.1039/C4RA01814A. - DOI
    5. Khusnutdinov R. I. Bayguzina A. R. Dzhemilev U. M. J. Organomet. Chem. 2014;768:75. doi: 10.1016/j.jorganchem.2014.06.008. - DOI
    6. Eftekhari-Sis B. Zirak M. Chem. Rev. 2015;115:151. doi: 10.1021/cr5004216. - DOI - PubMed
    7. Ramann G. A. Cowen B. J. Molecules. 2016;21:986. doi: 10.3390/molecules21080986. - DOI - PMC - PubMed
    8. Batista V. F. Pinto D. C. G. A. Silva A. M. S. ACS Sustainable Chem. Eng. 2016;4:4064. doi: 10.1021/acssuschemeng.6b01010. - DOI
    9. Chelucci G. Porcheddu A. Chem. Rec. 2017;17:200. doi: 10.1002/tcr.201600083. - DOI - PubMed
    1. Richter H. Mancheño O. G. Org. Lett. 2011;13:6066. doi: 10.1021/ol202552y. - DOI - PubMed
    2. Liu P. Wang Z. Lin J. Hu X. Eur. J. Org. Chem. 2012:1583. doi: 10.1002/ejoc.201101656. - DOI
    3. Liu P. Li Y. Wang H. Wang Z. Hu X. Tetrahedron Lett. 2012;53:6654. doi: 10.1016/j.tetlet.2012.09.090. - DOI
    4. Rohlmann R. Stopka T. Richter H. Mancheño O. G. J. Org. Chem. 2013;78:6050. doi: 10.1021/jo4007199. - DOI - PubMed